Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
35 /100
MEDIUM RISK
Score updated Oct 13, 2026

LXRX — Lexicon Pharmaceuticals, Inc. Dilution Risk Tracker

Track LXRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LXRX — Get alerts when the score changes →

As of October 13, 2026, Lexicon Pharmaceuticals, Inc. (LXRX) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Lexicon Pharmaceuticals, Inc. has a market capitalization of $734.18M, 444.96M shares outstanding, 138 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
40
📊 Float Risk
2
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split model est. 30%
• 50-day avg $1.84 approaching $1 threshold
🔔 Track LXRX — Get forecast alerts →

Market Data

Market Cap$734.18M
Shares Outstanding444.96M
Float394.68M
Cash$190.61M
Debt$51.44M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore35/100DilutionWatch score record
Shares Outstanding444.96MVerified float table or market cache
Public Float394.68MVerified float table or market cache
Market Cap$734.18MMarket data cache
Cash Runway15.7 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 4, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 29.0% shares (2026Q1 vs prior)
138 institutional holders · 337.31M shares
#1 Artal Group S.A. 154.73M shares
#2 FMR LLC 45.06M shares
#3 Siren, L.L.C. 44.30M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest25.83M
Days to Cover6.2
% of Float6.5%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-06
xbrl XBRL CONVERTIBLE 2026-03-05
8-K 8K EVENT 2026-04-30
4 INSIDER TRANSACTION 2026-03-03
4 INSIDER TRANSACTION 2026-03-03
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual LXRX Dilution Snapshot

Lexicon Pharmaceuticals, Inc. (LXRX) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

LXRX's DilutionScore is currently 35/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 39/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202635/100MEDIUM53 days
Aug 14 – Aug 21, 202639/100MEDIUM7 days
Jul 16 – Aug 13, 202632/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

LXRX shares outstanding have increased 6.3% from 417.87M (Mar 2026) to 444.20M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 21, 2026444.20M394.68M▼ 5.53%
Mar 12, 2026423.68M417.80M▼ 0.01%
Mar 11, 2026423.68M417.84M▲ 16.59%
Mar 05, 2026417.87M358.39M▼ 0.26%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track LXRX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment LXRX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking LXRX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for LXRX
LXRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.